Skip to main content

Advertisement

Log in

Review of bleomycin, ethanol and sodium tetradecyl sulfate as sclerosant agents in vascular malformations

Vergleich von Bleomycin, Ethanol und Natriumtetradecylsulfat als sklerosierende Wirkstoffe bei vaskulären Malformationen

  • Leitthema
  • Published:
Gefässchirurgie Aims and scope Submit manuscript

Abstract

Purpose

The aim of this article is to review the published literature on the use of bleomycin, ethanol and sodium tetradecyl sulfate as sclerosing embolic agents in vascular malformation management and contrast and compare them.

Material and methods

Published journal articles on bleomycin, ethanol and sodium tetradecyl sulfate employed in vascular malformation management were reviewed and the results were analyzed.

Results

While efficacy has been described for all the sclerosing embolic agents, absolute ethanol appears to be superior compared to others in that cures were routinely documented.

Conclusion

Absolute ethanol is highly effective in the permanent eradication and permanent ablation of high-flow and low-flow vascular malformations.

Zusammenfassung

Zweck

Das Ziel dieses Beitrags ist es, die publizierte Literatur zur Anwendung von Bleomycin, Ethanol und Natriumtetradecylsulfat als sklerosierende Wirkstoffe zur Behandlung vaskulärer Malformationen gegenüberzustellen und zu vergleichen.

Material und Methoden

Es wurden die Ergebnisse publizierter Beiträge zu Bleomycin, Ethanol und Natriumtetradecylsulfat zur Behandlung vaskulärer Malformationen analysiert.

Ergebnisse

Während die Wirksamkeit für alle sklerosierenden Embolisationswirkstoffe beschrieben wurde, scheint reines Ethanol im Vergleich zu anderen Wirkstoffen überlegen zu sein.

Schlussfolgerung

Reines Ethanol ist hochwirksam für die langfristige Eradikation und permanente Ablation von High-flow- und Low-flow-Gefäßmalformationen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. White RI Jr., Pollak J, Persing J, Henderson KJ, Thomson JG, Burdge CM (2000) Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations. J Vasc Interv Radiol 11:1285–1295

    Article  Google Scholar 

  2. Zanetti PH, Sherman FE (1972) Experimental evaluation of a tissue adhesive as an agent for the treatment of aneurysms and arteriovenous anomalies. J Neurosurg 36:72–79

    Article  CAS  Google Scholar 

  3. Kerber C (1976) Balloon catheter with a calibrated leak. A new system for superselective angiography and occlusive catheter therapy. Radiology 120:547–550

    Article  CAS  Google Scholar 

  4. Bank WO, Kerber CW, Cromwell LD (1981) Treatment of intracerebral arteriovenous malformations with isobutyl 2‑cyanoacrylate: initial clinical experience. Radiology 139:609–616

    Article  CAS  Google Scholar 

  5. Ellman BA, Parkhill BJ, Curry TS 3rd, Marcus PB, Peters PC (1981) Ablation of renal tumors with absolute ethanol: a new technique. Radiology 141:619–626

    Article  CAS  Google Scholar 

  6. Ellman BA, Green CE, Eigenbrodt E, Garriott JC, Curry TS (1980) Renal infarction with absolute ethanol. Invest Radiol 15:318–322

    Article  CAS  Google Scholar 

  7. Yakes WF (2015) Use of multiple Sclerosant agents in vascular malformation management: a world in Endovascular confusion and chaos. J Vasc Interv Radiol 26:1494–1496

    Article  Google Scholar 

  8. Ul Haq F, Mitchell SE, Tekes A, Weiss CR (2015) Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling. J Vasc Interv Radiol 26:1484–1493

    Article  Google Scholar 

  9. Hassan Y, Osman AK, Altyeb A (2013) Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection. Ann Plast Surg 70:70–73

    Article  CAS  Google Scholar 

  10. Sainsbury DC, Kessell G, Fall AJ, Hampton FJ, Guhan A, Muir T (2011) Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit. Plast Reconstr Surg 127:2031–2044

    Article  CAS  Google Scholar 

  11. Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF (2009) Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg 67:251–256

    Article  Google Scholar 

  12. Shigematsu T, Sorscher M, Dier EC, Berenstein A (2018) Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy. J Neurointerv Surg. https://doi.org/10.1136/neurintsurg-2018-013813

    Article  PubMed  Google Scholar 

  13. Zhang J, Li HB, Zhou SY et al (2013) Comparison between absolute ethanol and bleomycin for the treatment of venous malformation in children. Exp Ther Med 6:305–309

    Article  CAS  Google Scholar 

  14. Spence J, Krings T, TerBrugge KG, Agid R (2011) Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck 33:125–130

    Article  Google Scholar 

  15. Mendez-Echevarria A, Fernandez-Prieto A, de la Serna O et al (2018) Acute lung toxicity after Intralesional Bleomycin Sclerotherapy. Pediatrics. https://doi.org/10.1542/peds.2016-1787

    Article  PubMed  Google Scholar 

  16. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH (2003) Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 37:533–538

    Article  CAS  Google Scholar 

  17. Johnson PL, Eckard DA, Brecheisen MA, Girod DA, Tsue TT (2002) Percutaneous ethanol sclerotherapy of venous malformations of the tongue. Ajnr Am J Neuroradiol 23:779–782

    PubMed  Google Scholar 

  18. Su L, Fan X, Zheng L, Zheng J (2010) Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg 68:1622–1627

    Article  Google Scholar 

  19. Orlando JL, Caldas JG, Campos HG, Nishinari K, Wolosker N (2010) Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia. Clinics (Sao Paulo) 65:837–840

    Article  Google Scholar 

  20. Lee IH, Kim KH, Jeon P et al (2009) Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol 10:269–276

    Article  Google Scholar 

  21. Vogelzang RL, Atassi R, Vouche M, Resnick S, Salem R (2014) Ethanol embolotherapy of vascular malformations: clinical outcomes at a single center. J Vasc Interv Radiol 25:206–213 (quiz 14)

    Article  Google Scholar 

  22. Ali S, Weiss CR, Sinha A, Eng J, Mitchell SE (2016) The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology 31:603–609

    Article  Google Scholar 

  23. Guevara CJ, Gonzalez-Araiza G, Kim SK, Sheybani E, Darcy MD (2016) Sclerotherapy of diffuse and Infiltrative venous malformations of the hand and distal forearm. Cardiovasc Intervent Radiol 39:705–710

    Article  Google Scholar 

  24. Teusch VI, Wohlgemuth WA, Hammer S et al (2017) Ethanol-gel Sclerotherapy of venous malformations: effectiveness and safety. Ajr Am J Roentgenol 209:1390–1395

    Article  Google Scholar 

  25. Wang D, Su L, Han Y et al (2017) Direct intralesional ethanol sclerotherapy of extensive venous malformations with oropharyngeal involvement after a temporary tracheotomy in the head and neck: Initial results. Head Neck 39:288–296

    Article  Google Scholar 

  26. Park HS, Do YS, Park KB et al (2016) Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations. Eur Radiol 26:1301–1310

    Article  Google Scholar 

  27. Colletti G, Deganello A, Bardazzi A et al (2017) Complications after treatment of head and neck venous malformations with sodium Tetradecyl sulfate foam. J Craniofac Surg 28:e388–e392

    Article  Google Scholar 

  28. Kothary N, Soulen MC, Clark TW et al (2005) Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol 16:45–50

    Article  Google Scholar 

  29. Bakal CW, Cynamon J, Lakritz PS, Sprayregen S (1993) Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol 4:727–731

    Article  CAS  Google Scholar 

  30. Mukund A, Gamanagatti S (2010) Ethanol ablation of renal cell carcinoma for palliation of symptoms in advanced disease. J Palliat Med 13:117–120

    Article  Google Scholar 

  31. Usuki N, Nakamura K, Takashima S et al (1994) Embolization of varicocele with ethanol]. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiol 54:870–875

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Rohlffs.

Ethics declarations

Conflict of interest

F. E. V. Rohlffs and W. F. J. Yakes declare that they have no competing interests.

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rohlffs, F., Yakes, W.F. Review of bleomycin, ethanol and sodium tetradecyl sulfate as sclerosant agents in vascular malformations. Gefässchirurgie 23, 502–506 (2018). https://doi.org/10.1007/s00772-018-0461-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00772-018-0461-1

Keywords

Schlüsselwörter

Navigation